Source: Health Canada shortage reports · Updated Jul 23, 2026
Some Meloxicam products are in shortage in Canada (3 of 18 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Sep 4, 2026.
An anti-inflammatory (NSAID) used to relieve pain and inflammation from arthritis.
Products affected
3 / 18
In shortage since
Jan 8, 2020
Est. full return
Sep 4, 2026
Reports on file
72
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
APO-MELOXICAM
1.5G · SUSPENSION · APOTEX INC
DIN 02396467 · since Apr 28, 2026, est. end Sep 4, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-MELOXICAM
1.5G · SUSPENSION · APOTEX INC
DIN 02396467 · since Feb 4, 2025, est. end Mar 27, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-MELOXICAM
7.5MG · TABLET · TEVA CANADA LIMITED
DIN 02258315 · since Mar 10, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
ACT MELOXICAM
7.5MG · TABLET · TEVA CANADA LIMITED
DIN 02250012 · since Jan 8, 2020, no end estimate · Disruption of the manufacture of the drug.
Resolved
APO-MELOXICAM
1.5G · SUSPENSION · APOTEX INC
DIN 02396467 · ended Apr 9, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-MELOXICAM
15MG · TABLET · TEVA CANADA LIMITED
DIN 02258323 · ended Nov 19, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-MELOXICAM
1.5G · SUSPENSION · APOTEX INC
DIN 02396467 · ended Sep 18, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-MELOXICAM
1.5G · SUSPENSION · APOTEX INC
DIN 02396467 · ended Sep 11, 2025 · Disruption of the manufacture of the drug.
Resolved
AURO-MELOXICAM
7.5MG · TABLET · AURO PHARMA INC
DIN 02390884 · ended Jul 24, 2025 · Demand increase for the drug.
Resolved
APO-MELOXICAM
1.5G · SUSPENSION · APOTEX INC
DIN 02396467 · ended Jul 10, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-MELOXICAM
1.5G · SUSPENSION · APOTEX INC
DIN 02396467 · ended Mar 20, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-MELOXICAM
1.5G · SUSPENSION · APOTEX INC
DIN 02396467 · ended Mar 6, 2025 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Meloxicam is currently affected by 3 active shortage reports filed with Health Canada by APOTEX INC, TEVA CANADA LIMITED.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Recent changes
Jul 23, 2026
Estimated end date pushed back : Aug 21, 2026 → Sep 4, 2026
Jul 9, 2026
Estimated end date pushed back : Jul 10, 2026 → Aug 21, 2026
Common questions
What is Meloxicam used for?
An anti-inflammatory (NSAID) used to relieve pain and inflammation from arthritis.
When will Meloxicam be back in stock in Canada?
The latest manufacturer estimate is Sep 4, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Meloxicam in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.